SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma submits copy of press release

23 Dec 2015 Evaluate

Natco Pharma has submitted a copy of Press Release dated December 23, 2015 titled ‘NATCO announces REVLIMID Settlement with Celgene’.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

889.45 0.70 (0.08%)
22-Jun-2026 09:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.45
Dr. Reddys Lab 1275.00
Cipla 1385.10
Zydus Lifesciences 1068.80
Lupin 2367.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: